pcr-ssp and iplex massarray platform (Sequenom)
90
Structured Review
Sequenom
pcr-ssp and iplex massarray platform
Pcr Ssp And Iplex Massarray Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcr-ssp+and+iplex+massarray+platform/iplex+pcr/pm32388800-2-24-29
Average 90 stars, based on 1 article reviews
Pcr Ssp And Iplex Massarray Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcr-ssp+and+iplex+massarray+platform/iplex+pcr/pm32388800-2-24-29
Average 90 stars, based on 1 article reviews
pcr-ssp and iplex massarray platform - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: First Report of CR1 Polymorphisms and Soluble CR1 Levels Associated with Late Onset Alzheimer's Disease (LOAD) in Latin America. Article Snippet: TheCR1 gene has beenwidely studied in Alzheimer’s disease (AD), since its first association with the disease in 2009.. Even after 11 years of this discovery, the role of this gene in AD has not yet been fully elucidated and the association of its variants was not validated in Latin American populations.. We genotyped five CR1 single nucleotide polymorphisms (SNPs rs6656401, rs3849266, rs2274567, rs4844610, and rs12034383) in up to 162 AD patients and 137 controls through PCR-SSP and iPLEX MassARRAY Platform (Sequenom), and measured soluble CR1 (sCR1) levels in plasma of 40 AD patients and 39 controls with an enzyme-linked immunosorbent assay (ELISA). Clinical Proteomics:Article Title: First Report of CR1 Polymorphisms and Soluble CR1 Levels Associated with Late Onset Alzheimer's Disease (LOAD) in Latin America. Article Snippet: TheCR1 gene has beenwidely studied in Alzheimer’s disease (AD), since its first association with the disease in 2009.. Even after 11 years of this discovery, the role of this gene in AD has not yet been fully elucidated and the association of its variants was not validated in Latin American populations.. We genotyped five CR1 single nucleotide polymorphisms (SNPs rs6656401, rs3849266, rs2274567, rs4844610, and rs12034383) in up to 162 AD patients and 137 controls through PCR-SSP and iPLEX MassARRAY Platform (Sequenom), and measured soluble CR1 (sCR1) levels in plasma of 40 AD patients and 39 controls with an enzyme-linked immunosorbent assay (ELISA). Enzyme-linked Immunosorbent Assay:Article Title: First Report of CR1 Polymorphisms and Soluble CR1 Levels Associated with Late Onset Alzheimer's Disease (LOAD) in Latin America. Article Snippet: TheCR1 gene has beenwidely studied in Alzheimer’s disease (AD), since its first association with the disease in 2009.. Even after 11 years of this discovery, the role of this gene in AD has not yet been fully elucidated and the association of its variants was not validated in Latin American populations.. We genotyped five CR1 single nucleotide polymorphisms (SNPs rs6656401, rs3849266, rs2274567, rs4844610, and rs12034383) in up to 162 AD patients and 137 controls through PCR-SSP and iPLEX MassARRAY Platform (Sequenom), and measured soluble CR1 (sCR1) levels in plasma of 40 AD patients and 39 controls with an enzyme-linked immunosorbent assay (ELISA). |